Jeffrey S. Heier, Director at OCULAR THERAPEUTIX, INC (OCUL), bought 48,000 shares at $4.15 ($199K) on 2019-03-15, disclosed to the SEC on 2019-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.15 | 24,000 | $100K | 50.0% |
| 2 | $4.15 | 24,000 | $100K | 50.0% |
| Total | $4.15 avg | 48,000 | $199K | 100% |
| Filing → |
| OCUL | SELL | 2026-05-28 | $25K | — | Filing → |
| OCUL | SELL | 2026-02-25 | $25K | — | Filing → |
| OCUL | SELL | 2025-11-26 | $42K | — | Filing → |